Hydrostatin-SN10 treatment significantly inhibited the protein expression of p-STAT3 (Figure 7(c)) but no effect on the expression of JAK2 (Figure 7(d)) after 3- and 5-day model establishment in the HG group when compared with the MG group. Here, JAK2 is linked to myasthenia gravis.